Patents by Inventor Joseph P. Marino

Joseph P. Marino has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Preparation of 1,6-Disubstituted Azabenzimidazoles as Kinase Inhibitors
    Publication number: 20080234261
    Abstract: Novel inhibitors of Rho-kinases are disclosed.
    Type: Application
    Filed: October 6, 2004
    Publication date: September 25, 2008
    Inventors: Dennis Lee, Robert A. Stavenger, Krista A. Goodman, Mark A. Hilfiker, Haifeng Cui, Andrew Q. Viet, Joseph P. Marino
  • 1,2,4-triazole derivatives, compositions, process of making and methods of use
    Patent number: 7304082
    Abstract: Compounds of this invention are non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis, ocular neovascularization and obesity.
    Type: Grant
    Filed: July 21, 2005
    Date of Patent: December 4, 2007
    Assignee: SmithKline Beecham Corporation
    Inventors: Joseph P. Marino, Jr., Scott K. Thompson, Daniel Frank Veber
  • Amide compounds and methods of using the same
    Patent number: 7247748
    Abstract: Disclosed is a compound having the formula (I) pharmaceutically acceptable salts or solvates thereof and pharmaceutical compositions containing the same, wherein the structural variables are as defined herein.
    Type: Grant
    Filed: March 26, 2003
    Date of Patent: July 24, 2007
    Assignee: SmithKline Corporation
    Inventors: Scott K. Thompson, James S. Frazee, Lara S. Kallander, Chun Ma, Joseph P. Marino, Michael J. Neeb, Ning Wang
  • Compounds and methods
    Publication number: 20040116490
    Abstract: Compounds of this invention are non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis, ocular neovascularization and obesity.
    Type: Application
    Filed: February 20, 2004
    Publication date: June 17, 2004
    Inventors: Joseph P. Marino Jr., Scott K. Thompson, Daniel Frank Veber
  • Compounds and methods
    Publication number: 20040116495
    Abstract: Compounds of this invention are non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis, ocular neovascularization and obesity.
    Type: Application
    Filed: February 19, 2004
    Publication date: June 17, 2004
    Inventors: Joseph P. Marino Jr., Scott K. Thompson, Daniel Frank Veber